LGND Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc is a biopharmaceutical company. Its business model is based upon the concept of acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.

$151.15  -5.77 (-3.68%)
As of 12/03/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/23/2001
Outstanding shares:  16,711,641
Average volume:  133,203
Market cap:   $2,622,390,706
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    53220K504
ISIN:        US53220K5048
Sedol:      2501578
Valuation   (See tab for details)
PE ratio:   36.87
PB ratio:   3.10
PS ratio:   9.55
Return on equity:   8.41%
Net income %:   24.87%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy